Australian Genetics of Depression Study: Anti-depressant Cell-omics

People differ in the symptoms they experience as part of their depression and the way in which they respond to treatments. Our long-term goal is that treatments should be tailored to individuals rather than a “one size fits all” approach. This concept of personalised medicine is already applied in other health settings, for example cancer care. To advance this in depression requires more research to understand differences between people.

About the Study

What is the purpose of the research?

To advance our long-term goal that treatments should be tailored to individuals, we plan to conduct assays on cells to discover biological and genetic mechanisms that link to the differences between people in their responses to antidepressants.

From blood cells we can derive induced pluripotent stem cells (iPSCs). The iPSCs can be reprogrammed to form any cell type in the body including brain cells (see the video below). This exciting research is being conducted worldwide to study many diseases, but to date there are no comprehensive studies which link iPSCs measurements to in-person responses to antidepressants.

What does participation in this research involve?

We will ask you to complete an online questionnaire about your personal experiences of depression focussing on symptoms and response to treatments. The questionnaire will take about 30 minutes to complete. We will ask you to provide a blood sample by attending a local pathology clinic.

We would like to acknowledge and thank Professor Alex Hewitt, University of Tasmania, and colleagues for the use of this You tube video “What to expect if you participate in iPSC research”. He created this video for his research of eye diseases deriving iPSCs from skin cells. The goals of his research were different from ours, but the iPSC principles are the same.

How to participate?

Step 1 (10 mins) – Read the participant Information and Consent form; and decide whether you would like to participate.
Step 2 (30 – 40 mins) – Answer questions about your depression and treatment.
Confirm mailing address so we can send a sample collection kit.
Step 3 (10 mins) – Attend your local pathology collection centre to provide a blood sample.
Step 4 (1 min) – Email us that you have sent your blood sample to us. Once we receive your sample we will send you your gift card.

Announcements

📣 Call for AGDS Participants – We need you!

We previously invited you to join the AGDS: Cell-Omics study to help us understand which antidepressants work for each person and why. So far, 578 AGDS participants have joined. We need to double this and reach 1000 to obtain clinically meaningful outcomes. Please sign up now for this exciting study. Our funding runs out in September. Read more

💬 Join Our Lived Experience Group

We are looking for people who have lived with depression and want to help us share the science behind our research in a way that makes sense to others. You do not need any special skills – just your experience and interest in helping. If you are interested, email cello@uq.edu.au with:

  • Your name
  • Your contact number
  • A short message saying you are interested

We would love to hear from you!

Contact Us

cello@uq.edu.au
07 3346 2089
Ms Deborah Gilroy
Institute for Molecular Bioscience, University of Queensland
Donate now

Get In Touch

If you have any further questions, please contact us via email at
cello@uq.edu.au

Please subscribe to our mailing list to stay informed.

What to expect if you participate in iPSC research

We like to acknowledge and thank Professor Alex Hewitt, University of Tasmania, and colleagues for the use of this You tube video “What to expect if you participate in iPSC research”.
Please note that in our study, participants are only requested to provide a blood sample for the generation of iPSCs.

About HSU

The Human Studies Unit at the University of Queensland is supporting the Cello study. At HSU, we combine laboratory and computing expertise to generate genomic data, and provide data management solutions, to advance understanding of common complex diseases and benefit those affected by them.

Scroll to Top